Genomics in Patient Care and Workforce Decisions in High-Level Isolation Units: A Survey of Healthcare Workers
- PMID: 33826422
- PMCID: PMC8217591
- DOI: 10.1089/hs.2020.0182
Genomics in Patient Care and Workforce Decisions in High-Level Isolation Units: A Survey of Healthcare Workers
Abstract
The impact of host genomics on an individual's susceptibility, immune response, and risk of severe outcomes for a given infectious pathogen is increasingly recognized. As we uncover the links between host genomics and infectious disease, a number of ethical, legal, and social issues need to be considered when using that information in clinical practice or workforce decisions. We conducted a survey of the clinical staff at 10 federally funded Regional Ebola and Other Special Pathogen Treatment Centers to understand their views regarding the ethical, legal, and social issues related to host genomics and the administrative and clinical functions of high-level isolation units. Respondents overwhelmingly agreed that genomics could provide valuable information to identify patients and employees at higher risk for poor outcomes from highly infectious diseases. However, there was considerable disagreement about whether such data should inform the allocation of scarce resources or determine treatment decisions. While most respondents supported a confidential employer-based genomic testing system to inform individual employees about risk, respondents disagreed about whether such information should be used in staffing models. Respondents who thought genomic information would be valuable for patient treatment were more willing to undergo genetic testing for staffing purposes. Most respondents felt they would benefit from additional training to better interpret results from genetic testing. Although this study was completed before the COVID-19 pandemic, the responses provide a baseline assessment of provider attitudes that can inform policy during the current pandemic and in future infectious disease outbreaks.
Keywords: Biocontainment; Bioethics; COVID-19; ELSI; Epidemic Management/response; Genomics; Resource allocation.
Similar articles
-
The ethics of using COVID-19 host genomic information for clinical and public health decision-making: A survey of US health professionals.HGG Adv. 2024 Jan 11;5(1):100255. doi: 10.1016/j.xhgg.2023.100255. Epub 2023 Nov 17. HGG Adv. 2024. PMID: 37978805 Free PMC article.
-
Genomics and High-Consequence Infectious Diseases: A Scoping Review of Emerging Science and Potential Ethical Issues.Health Secur. 2019 Jan/Feb;17(1):62-68. doi: 10.1089/hs.2018.0108. Epub 2019 Feb 6. Health Secur. 2019. PMID: 30724614 Free PMC article.
-
Ethics of emerging infectious disease outbreak responses: Using Ebola virus disease as a case study of limited resource allocation.PLoS One. 2021 Feb 2;16(2):e0246320. doi: 10.1371/journal.pone.0246320. eCollection 2021. PLoS One. 2021. PMID: 33529237 Free PMC article.
-
The Impact of High-Level Isolation Units Beyond High-Consequence Pathogen Preparedness.Health Secur. 2019 Jan/Feb;17(1):69-73. doi: 10.1089/hs.2018.0104. Health Secur. 2019. PMID: 30779609
-
The translational potential of research on the ethical, legal, and social implications of genomics.Genet Med. 2015 Jan;17(1):12-20. doi: 10.1038/gim.2014.74. Epub 2014 Jun 19. Genet Med. 2015. PMID: 24946153 Free PMC article. Review.
Cited by
-
A narrative review of high-level isolation unit operational and infrastructure features.BMJ Glob Health. 2023 Jul;8(7):e012037. doi: 10.1136/bmjgh-2023-012037. BMJ Glob Health. 2023. PMID: 37423621 Free PMC article. Review.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials